CARRIE FLURY: Open Payments
NPI 1841287471 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 37 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $872 · 2025 $755
Food & beverage: $655Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $311 |
| Regeneron Healthcare Solutions, Inc. | 6 | $119 |
| Lilly USA, LLC | 4 | $86 |
| ABBVIE INC. | 4 | $73 |
| Galderma Laboratories, L.P. | 4 | $73 |
| Amgen Inc. | 2 | $38 |
| Krystal Biotech Inc | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| GENZYME CORPORATION | 1 | $15 |
Products named: TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, TALTZ, Otezla, EBGLYSS, VYJUVEK.
Industry payments across NM — which companies pay providers there.
